The Role of K+Channels in Determining Pulmonary Vascular Tone, Oxygen Sensing, Cell Proliferation, and Apoptosis: Implications in Hypoxic Pulmonary Vasoconstriction and Pulmonary Arterial Hypertension
- 1 December 2006
- journal article
- review article
- Published by Wiley in Microcirculation
- Vol. 13 (8) , 615-632
- https://doi.org/10.1080/10739680600930222
Abstract
Potassium channels are tetrameric, membrane‐spanning proteins that selectively conduct K+at near diffusion‐limited rates. Their remarkable ionic selectivity results from a highly‐conserved K+recognition sequence in the pore. The classical function of K+channels is regulation of membrane potential (EM) and thence vascular tone. In pulmonary artery smooth muscle cells (PASMC), tonic K+egress, driven by a 145/5 mM intracellular/extracellular concentration gradient, contributes to aEMof about −60 mV. It has been recently discovered that K+channels also participate in vascular remodeling by regulating cell proliferation and apoptosis. PASMC express voltage‐gated (Kv), inward rectifier (Kir), calcium‐sensitive (KCa), and two‐pore (K2P) channels. Certain K+channels are subject to rapid redox regulation by reactive oxygen species (ROS) derived from the PASMC's oxygen‐sensor (mitochondria and/or NADPH oxidase). Acute hypoxic inhibition of ROS production inhibits Kv1.5, which depolarizesEM, opens voltage‐sensitive, L‐type calcium channels, elevates cytosolic calcium, and initiates hypoxic pulmonary vasoconstriction (HPV). Hypoxia‐inhibited K+currents are not seen in systemic arterial SMCs. Kvexpression is also transcriptionally regulated by HIF‐1α and NFAT. Loss of PASMC Kv1.5 and Kv2.1 contributes to the pathogenesis of pulmonary arterial hypertension (PAH) by causing a sustained depolarization, which increases intracellular calcium and K+, thereby stimulating cell proliferation and inhibiting apoptosis, respectively. Restoring Kvexpression (via Kv1.5 gene therapy, dichloroacetate, or anti‐survivin therapy) reduces experimental PAH. Electrophysiological diversity exists within the pulmonary circulation. Resistance PASMC have a homogeneous Kvcurrent (including an oxygen‐sensitive component), whereas conduit PASMC current is a Kv/KCamosaic. This reflects regional differences in expression of channel isoforms, heterotetramers, splice variants, and regulatory subunits as well as mitochondrial diversity. In conclusion, K+channels regulate pulmonary vascular tone and remodeling and constitute potential therapeutic targets in the regression of PAH.Keywords
This publication has 127 references indexed in Scilit:
- International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium ChannelsPharmacological Reviews, 2005
- International Union of Pharmacology. LV. Nomenclature and Molecular Relationships of Two-P Potassium ChannelsPharmacological Reviews, 2005
- International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium ChannelsPharmacological Reviews, 2005
- Acute Oxygen-Sensing MechanismsNew England Journal of Medicine, 2005
- Crystal Structure of a Mammalian Voltage-Dependent Shaker Family K + ChannelScience, 2005
- A Mutant KcsA K+ Channel with Altered Conduction Properties and Selectivity Filter Ion DistributionJournal of Molecular Biology, 2004
- Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage‐gated potassium channel Kv1.5The FASEB Journal, 2001
- Inactivation properties of voltage-gated K+ channels altered by presence of β-subunitNature, 1994
- Modulation of K+ channels by hydrogen peroxideBiochemical and Biophysical Research Communications, 1992
- Potassium channels expressed from rat brain cDNA have delayed rectifier propertiesFEBS Letters, 1988